Antimicrobial Resistance News and Research

RSS

Extensively drug-resistant Neisseria gonorrhoeae strain recently identified in Austria

Given that there is no vaccine available against gonorrhea, diagnosing this sexually transmitted infection early, treating it effectively and notifying sexual partners are cornerstones of controlling disease spread.

16 Jun 2022

Research reveals a potential Achilles heel in the protective layers surrounding Gram-negative bacteria

A new study published in Nature today has identified a potential Achilles heel in the protective layers surrounding Gram-negative bacteria that could aid in the development of next-generation antibiotics.

15 Jun 2022

Study reveals how common drug-resistant superbug responds to ‘last resort’ antibiotic

A study published today in Cell Reports reveals how populations of a bacterium called Pseudomonas respond to being treated with Colistin, a 'last resort' antibiotic for patients who have developed multi-drug resistant infections.

7 Jun 2022

UK and Sweden commit to enhance co-operation in the life sciences

Today (27 May 2022), Parliamentary Under-Secretary of State for Innovation at the Department of Health and Social Care, Lord Kamall, and the Swedish Minister for Education, Anna Ekström, signed a Memorandum of Understanding (MoU) committing the UK and Sweden to ongoing co-operation in the life sciences.

27 May 2022

Researchers discover bifunctional lipopeptide antibiotic with a low resistance potential

Through bioinformatic prospecting, researchers discovered and synthesized a novel, naturally inspired bifunctional lipopeptide antibiotic with a low resistance potential.

27 May 2022

Exposure of microbial communities to antibiotics could facilitate the spread of plasmid-encoded genes

DNA molecules called plasmids – some of which protect bacteria from antibiotics – can spread rapidly through bacterial "communities" that are treated with antibiotics, new research shows.

27 May 2022

Researchers focus on how bacterial cells adapt and resist antibiotics

Treatment of severe infections caused by pathogenic bacteria relies on ‘last resort’ antibiotics, but rising resistance by ‘superbugs’ to most clinically approved drugs leaves patients exposed to possible fatalities.

26 May 2022

STIs could be prevented with a dose of doxycycline after unprotected sex

A significant proportion of bacterial sexually transmitted infections (STIs) - gonorrhea, chlamydia or syphilis - were prevented with a dose of doxycycline after unprotected sex, according to preliminary results of a clinical trial that closed early because it was very effective for men who have sex with men and transgender women who are living with HIV or are taking HIV pre-exposure prophylaxis (PrEP).

25 May 2022

HKUMed researchers report the effects of SARS-CoV-2 on bone metabolism

A research team led by Professor Kelvin Yeung Wai-kwok and Dr Jasper Chan Fuk-woo from the LKS Faculty of Medicine, The University of Hong Kong (HKUMed) discovered that SARS-CoV-2 infection can cause inflammatory activation of bone resorption cells, leading to severe bone loss during the acute and post-recovery phases of COVID-19.

25 May 2022

University of Minnesota receives $66 million to establish new antiviral drug discovery center

The University of Minnesota has received $66 million from the National Institute of Allergy and Infectious Diseases to establish a center to develop antiviral drugs for pandemic-level viruses, including SARS-CoV-2.

23 May 2022

G7 health ministers sign landmark pact to make the world better prepared for future pandemics

A landmark pact signed by G7 health ministers in Berlin will help ensure the world is better prepared for future pandemics.

20 May 2022

New funding boost to combat antibiotic resistance

Antibiotics have saved countless lives since they were introduced in the 1940s, curing infections and making procedures like chemotherapy and surgeries safer. But their effectiveness is waning.

19 May 2022

Developing innovative approaches to combat urinary tract infections

The German government is providing about 2.4 million Euros for a new research group in infectious diseases at JMU Würzburg.

18 May 2022

IVI and partners to provide two doses of oral vaccine to 100,000 people at risk of cholera in Ethiopia

The International Vaccine Institute, in collaboration with LG Electronics, the Ethiopian government led by Armauer Hansen Research Institute, and the Ethiopian Public Health Institute, will vaccinate 40,000 people against cholera in May to support prevention of the disease in Ethiopia.

13 May 2022

SK bioscience's typhoid vaccine licensed for export by Korean Ministry of Food and Drug Safety

The International Vaccine Institute (IVI) and SK bioscience announced today that SK bioscience obtained an export license from the Korean Ministry of Food and Drug Safety for SK's typhoid vaccine 'SKYTyphoid' which they jointly developed.

12 May 2022

How is the Antimicrobial Resistance Crisis Impacting Sepsis?

In this interview, News-Medical talks to Dr. Ron Daniels about his work at the UK Sepsis Trust and the impact antimicrobial resistance is having on sepsis.

11 May 2022

Diet with higher amounts of soluble fiber may be a solution to reduce antimicrobial resistance

Healthy adults who eat a diverse diet with at least 8-10 grams of soluble fiber a day have fewer antibiotic-resistant microbes in their guts, according to a study published by Agricultural Research Service scientists and their colleagues in mBio.

10 May 2022

SARS-CoV-2 develops partial resistance to the antiviral drug remdesivir in cell culture

The virus that causes COVID-19 can develop partial resistance to the antiviral drug remdesivir during infection of cultured cells in the laboratory by more than one mechanism.

5 May 2022

Researchers use a systems biology approach to parse the genetic diversity of C. difficile

Researchers at University of California San Diego School of Medicine and Jacobs School of Engineering, with colleagues at Baylor College of Medicine, have used a systems biology approach to parse the genetic diversity of Clostridioides difficile, a particularly problematic pathogen in health care settings.

27 Apr 2022

Study finds antimicrobial resistance rates to be significantly higher during the pandemic than before

Among those hospitalized during the pandemic, both COVID-19 patients and those tested for SARS-COV-2 but negative, had higher rates of antibiotic-resistant bacterial infections compared to patients hospitalized before the pandemic, according to a study evaluating the pandemic's impact on antimicrobial resistance (AMR) in 271 hospitals across the USA, to be presented at this year's European Congress of Clinical Microbiology & Infectious Diseases in Lisbon, Portugal (23-26 April).

25 Apr 2022

Antimicrobial Resistance News and Research

Extensively drug-resistant Neisseria gonorrhoeae strain recently identified in Austria

Research reveals a potential Achilles heel in the protective layers surrounding Gram-negative bacteria

Study reveals how common drug-resistant superbug responds to ‘last resort’ antibiotic

UK and Sweden commit to enhance co-operation in the life sciences

Researchers discover bifunctional lipopeptide antibiotic with a low resistance potential

Exposure of microbial communities to antibiotics could facilitate the spread of plasmid-encoded genes

Researchers focus on how bacterial cells adapt and resist antibiotics

STIs could be prevented with a dose of doxycycline after unprotected sex

HKUMed researchers report the effects of SARS-CoV-2 on bone metabolism

University of Minnesota receives $66 million to establish new antiviral drug discovery center

G7 health ministers sign landmark pact to make the world better prepared for future pandemics

New funding boost to combat antibiotic resistance

Developing innovative approaches to combat urinary tract infections

IVI and partners to provide two doses of oral vaccine to 100,000 people at risk of cholera in Ethiopia

SK bioscience's typhoid vaccine licensed for export by Korean Ministry of Food and Drug Safety

How is the Antimicrobial Resistance Crisis Impacting Sepsis?

Diet with higher amounts of soluble fiber may be a solution to reduce antimicrobial resistance

SARS-CoV-2 develops partial resistance to the antiviral drug remdesivir in cell culture

Researchers use a systems biology approach to parse the genetic diversity of C. difficile

Study finds antimicrobial resistance rates to be significantly higher during the pandemic than before

Microbiology eBook

Achieving and maintaining ISO/IEC 27001 and BS 10012 certifications

Expanding research and clinical options for children with cancer

Examining how pain could play a direct protective role in the gut

Latest News